搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
xers
/
财务摘要
Xeris Biopharma Holdings Inc
XERS
添加自选
8.200
USD
+0.040
+0.49%
收盘 09-18 16:00(美东)
1.42B
总市值
106.45
市盈率 TTM
Xeris Biopharma Holdings Inc
8.200
+0.040
+0.49%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
XERS 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Xeris Biopharma Holdings Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
1.42B
股息TTM
0.00
市盈率 TTM
106.45
每股收益TTM
0.08
营业收入
291.85M
净利润
-54.84M
净资产收益率
-617.16%
总资产收益率
3.39%
Xeris Biopharma Holdings Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.18
/0.00
营业收入 / 预测值
92.10M
/90.22M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-1388.50%
-0.18
121.66%
0.01
294.75%
0.07
103.59%
0.00
88.05%
-0.01
55.23%
-0.06
64.65%
-0.03
-19.64%
-0.11
29.99%
-0.10
-10.04%
-0.14
-1.96%
-0.10
--
-0.09
--
-0.14
--
-0.12
--
-0.10
--
-0.60
--
--
--
--
--
--
--
--
营业收入
28.74%
92.10M
38.27%
83.13M
42.78%
85.81M
37.06%
74.38M
48.84%
71.54M
47.94%
60.12M
35.39%
60.10M
12.31%
54.27M
26.46%
48.06M
22.42%
40.64M
33.93%
44.39M
62.56%
48.32M
50.19%
38.01M
50.39%
33.20M
54.67%
33.14M
168.76%
29.73M
184.15%
25.31M
169.35%
22.07M
198.79%
21.43M
17.06%
11.06M
净利润
-1513.12%
-31.10M
124.23%
2.23M
316.72%
11.08M
103.95%
621.00K
87.15%
-1.93M
51.42%
-9.22M
61.81%
-5.11M
-29.12%
-15.74M
24.38%
-15.01M
-12.75%
-18.98M
-3.56%
-13.39M
44.17%
-12.19M
24.22%
-19.84M
50.07%
-16.83M
74.54%
-12.93M
16.06%
-21.83M
4.83%
-26.18M
-83.12%
-33.71M
-132.37%
-50.79M
-62.56%
-26.01M
利润率
-1153.00%
-33.77%
117.52%
2.69%
251.79%
12.91%
102.88%
0.83%
91.37%
-2.70%
67.16%
-15.34%
71.80%
-8.51%
-14.96%
-29.00%
40.20%
-31.22%
7.90%
-46.71%
22.68%
-30.16%
--
-25.23%
--
-52.20%
--
-50.71%
--
-39.01%
--
-106.00%
--
--
--
--
--
--
--
--
毛利率
4.89%
83.47%
3.76%
84.02%
5.47%
84.08%
16.60%
81.57%
1.82%
79.58%
2.97%
80.97%
3.75%
79.72%
-9.64%
69.96%
7.07%
78.15%
3.73%
78.64%
5.49%
76.84%
--
77.42%
--
72.99%
--
75.81%
--
72.84%
--
68.26%
--
--
--
--
--
--
--
--
资产负债率
-6.12%
61.32%
-22.52%
56.43%
-20.04%
57.45%
-17.69%
59.29%
-5.98%
65.32%
6.75%
72.84%
21.39%
71.85%
23.98%
72.03%
21.39%
69.48%
16.86%
68.23%
9.00%
59.19%
--
58.09%
--
57.24%
--
58.38%
--
54.30%
--
45.71%
--
--
--
--
--
--
--
--
利润表
营业收入
28.74%
92.10M
38.27%
83.13M
42.78%
85.81M
37.06%
74.38M
48.84%
71.54M
47.94%
60.12M
35.39%
60.10M
12.31%
54.27M
26.46%
48.06M
22.42%
40.64M
33.93%
44.39M
62.56%
48.32M
50.19%
38.01M
50.39%
33.20M
54.67%
33.14M
168.76%
29.73M
184.15%
25.31M
169.35%
22.07M
198.79%
21.43M
17.06%
11.06M
营业利润
15.42%
5.17M
356.18%
7.92M
898.99%
16.77M
152.21%
6.73M
154.75%
4.48M
78.31%
-3.09M
117.06%
1.68M
-162.43%
-12.89M
48.76%
-8.19M
-7.29%
-14.24M
35.13%
-9.84M
73.70%
-4.91M
15.53%
-15.98M
30.39%
-13.28M
67.07%
-15.17M
15.31%
-18.68M
13.57%
-18.92M
-16.02%
-19.07M
-138.18%
-46.07M
-60.49%
-22.06M
净利润
-1513.12%
-31.10M
124.23%
2.23M
316.72%
11.08M
103.95%
621.00K
87.15%
-1.93M
51.42%
-9.22M
61.81%
-5.11M
-29.12%
-15.74M
24.38%
-15.01M
-12.75%
-18.98M
-3.56%
-13.39M
44.17%
-12.19M
24.22%
-19.84M
50.07%
-16.83M
74.54%
-12.93M
16.06%
-21.83M
4.83%
-26.18M
-83.12%
-33.71M
-132.37%
-50.79M
-62.56%
-26.01M
资产负债表
流动资产
48.05%
274.76M
53.94%
251.68M
43.33%
240.31M
37.60%
224.02M
8.95%
185.58M
-5.65%
163.49M
7.29%
167.66M
3.00%
162.80M
9.37%
170.34M
4.69%
173.28M
-16.35%
156.26M
6.13%
158.05M
-3.39%
155.74M
-6.78%
165.51M
31.01%
186.82M
19.74%
148.92M
11.49%
161.21M
10.54%
177.55M
-6.32%
142.60M
-23.81%
124.37M
流动负债总额
99.19%
189.57M
24.74%
118.59M
9.09%
109.57M
27.67%
116.20M
26.07%
95.17M
30.09%
95.07M
5.52%
100.44M
4.57%
91.01M
-5.26%
75.49M
-10.24%
73.08M
29.30%
95.19M
26.96%
87.04M
23.45%
79.68M
22.46%
81.42M
-6.86%
73.62M
83.88%
68.56M
82.00%
64.55M
142.46%
66.49M
180.21%
79.04M
37.95%
37.28M
总资产
23.07%
411.90M
24.27%
392.01M
18.72%
383.53M
15.29%
370.19M
0.89%
334.69M
-6.29%
315.45M
0.14%
323.06M
-2.04%
321.10M
0.90%
331.73M
4.75%
336.62M
-6.36%
322.60M
8.17%
327.78M
3.19%
328.78M
-4.82%
321.36M
13.20%
344.52M
130.85%
303.02M
110.31%
318.62M
101.40%
337.62M
91.24%
304.36M
-22.96%
131.26M
总负债
19.11%
421.64M
8.11%
379.00M
4.87%
369.84M
6.19%
371.05M
0.85%
353.99M
1.38%
350.58M
7.07%
352.68M
7.87%
349.43M
11.39%
351.02M
18.70%
345.79M
10.04%
329.38M
30.62%
323.92M
28.80%
315.14M
20.79%
291.31M
43.13%
299.33M
85.44%
247.98M
85.91%
244.67M
95.67%
241.17M
66.78%
209.13M
-14.31%
133.72M
总权益
49.58%
-9.73M
137.04%
13.01M
146.22%
13.69M
96.96%
-861.00K
-0.09%
-19.30M
-282.74%
-35.13M
-336.67%
-29.61M
-832.81%
-28.32M
-241.38%
-19.29M
-130.54%
-9.18M
-115.01%
-6.78M
-92.98%
3.87M
-81.55%
13.64M
-68.85%
30.05M
-52.55%
45.19M
2336.49%
55.04M
271.80%
73.94M
117.30%
96.45M
182.07%
95.23M
-117.17%
-2.46M
现金流量表
经营净额
4440.11%
8.26M
198.39%
9.87M
914.84%
20.04M
321.94%
18.43M
101.76%
182.00K
50.59%
-10.03M
-73.56%
1.98M
43.16%
-8.30M
24.71%
-10.35M
22.33%
-20.30M
146.35%
7.47M
17.71%
-14.61M
33.31%
-13.74M
46.00%
-26.14M
44.31%
-16.12M
21.48%
-17.75M
-2.93%
-20.61M
-102.07%
-48.41M
-166.32%
-28.95M
-33.12%
-22.61M
投资净额
25.09%
-209.00K
-2400.00%
-325.00K
-103.32%
-333.00K
-100.72%
-71.00K
-106.06%
-279.00K
99.93%
-13.00K
-32.63%
10.02M
-32.35%
9.91M
-45.54%
4.60M
55.32%
-19.65M
62.17%
14.87M
118.44%
14.65M
-28.78%
8.45M
-754.84%
-43.98M
-74.95%
9.17M
-63.74%
6.71M
-28.32%
11.87M
-74.46%
6.72M
404.92%
36.60M
130.50%
18.50M
融资净额
106.26%
1.94M
-181.70%
-8.84M
-166.83%
-266.00K
16786.75%
13.85M
42.94%
942.00K
-108.91%
-3.14M
132.25%
398.00K
-15.28%
-83.00K
18.53%
659.00K
4178.10%
35.19M
-102.51%
-1.23M
61.50%
-72.00K
79.35%
556.00K
-101.10%
-863.00K
39224.80%
49.16M
-18800.00%
-187.00K
-32.61%
310.00K
193.29%
78.19M
-96.24%
125.00K
-99.99%
1.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Xeris Biopharma Holdings Inc的总收入是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,总收入达到了291.85M(同比变化203.07M)。
Xeris Biopharma Holdings Inc的流动资产是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,流动资产为240.31M(同比变化43.33)。
Xeris Biopharma Holdings Inc的总资产是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的总资产为383.53M(同比变化18.72)。
Xeris Biopharma Holdings Inc的总负债是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的总负债为369.84M(同比变化4.87)。
Xeris Biopharma Holdings Inc的总权益是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的总权益为13.69M(同比变化146.22)。
Xeris Biopharma Holdings Inc的净营业收入是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的净营业收入为24.90M(同比变化173.99)。
Xeris Biopharma Holdings Inc的净投资是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的净投资为-696.00K(同比变化-114.25)。
Xeris Biopharma Holdings Inc的净融资是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,Xeris Biopharma Holdings Inc的净融资为11.39M(同比变化-68.51)。
Xeris Biopharma Holdings Inc的净利润是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,净利润为554.00K(同比变化101.01)。
Xeris Biopharma Holdings Inc的净利润率是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,净利润率为0.19(同比变化100.70)。
Xeris Biopharma Holdings Inc的毛利率是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,毛利率为81.70(同比变化6.76)。
Xeris Biopharma Holdings Inc的债务与资产比率是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,债务与资产比率为57.45(同比变化-20.04)。
Xeris Biopharma Holdings Inc的资产回报率(ROA)是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,资产回报率(ROA)为0.16(同比变化100.92)。
Xeris Biopharma Holdings Inc的营业利润是多少?
根据Xeris Biopharma Holdings Inc的FY2025财报,营业利润为24.90M(同比变化173.99)。